1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Research
2.2. Quantitative Research
2.3. Market Breakdown & Data Triangulation
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents, By Region
2.5. Assumption & Limitation
3. Executive Summary
4. Saudi Arabia Pharmaceutical Market Insights
4.1. Industry Value Chain Analysis
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Recent Development/Technological Landscape
4.4. Regulatory Framework
4.5. Porters Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Intensity of Rivalry
5. Saudi Arabia Pharmaceutical Market Overview
5.1. Market Size & Forecast by Value, 2018-2028
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Drug Type
5.2.1.1. Generic Drugs
5.2.1.2. Branded Drugs
5.2.2. By Product Type
5.2.2.1. Prescription drugs
5.2.2.2. Over the Counter Drugs
5.2.3. By Application
5.2.3.1. Cardiovascular
5.2.3.2. Musculoskeletal
5.2.3.3. Oncology
5.2.3.4. Anti-infective
5.2.3.5. Metabolic Disorder
5.2.3.6. Central Nervous System
5.2.3.7. Gastrointestinal
5.2.3.8. Respiratory
5.2.3.9. Hematology
5.2.3.10. Others (Dermatology, Ophthalmology, Nutraceutical, Dental, and Veterinarian)
5.2.4. By Distribution Channel
5.2.4.1. Hospital Pharmacy
5.2.4.2. Retail Pharmacy
5.2.4.3. Online Pharmacy
6. Competitive Landscape
6.1. List of Key Players and Their Offerings
6.2. Market Share Analysis, 2021
6.3. Competitive Benchmarking, By Operating Parameters
6.4. Key Strategic Development (Merger, Acquisition, Partnership.)
7. Impact of COVID-19 on Saudi Arabia Pharmaceutical Market Industry
8. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)
8.1. Pfizer Inc.
8.2. Sanofi S.A.
8.3. AstraZeneca
8.4. GlaxoSmithCline Plc
8.5. Life Care group of Pharmacies
8.6. Baxter International Inc.
8.7. Planet Pharmacies (Zahrat Al Rawdah)
8.8. Tadawi Pharmacies
8.9. Al Nahdi medical
8.10. Al-Safwwa Pharmacals
8.11. Tabuk Pharmaceuticals
8.12. Hikma Pharmaceuticals PLC
8.13. Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO)
8.14. Jamjoom Pharmaceuticals Co.
8.15. Jhulphar
8.16. Other Prominent Players.
9. Key Strategic Recommendations